GLPwatch
Oral GLP-1 receptor agonists for the treatment of obesity: ATTAINing metabolic benefits to find the OASIS.
Expert Rev Endocrinol Metab · 2026
Last updated 2026-05-28| Journal | Expert Rev Endocrinol Metab, 2026 |
|---|---|
| Citations | 0 |
| Molecules | — |
| Conditions studied | Obesity |
Full record and abstract on PubMed 41742335 ↗